Cargando…
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
Malignant cells are susceptible to viral infection and consequent cell death. Virus-induced cell death is endowed with features that are known to stimulate innate and adaptive immune responses. Thus danger signals emitted by cells succumbing to viral infection as well as viral nucleic acids are dete...
Autores principales: | Quetglas, José I., John, Liza B., Kershaw, Michael H., Álvarez-Vallina, Luis, Melero, Ignacio, Darcy, Phillip K., Smerdou, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518506/ https://www.ncbi.nlm.nih.gov/pubmed/23243597 http://dx.doi.org/10.4161/onci.21679 |
Ejemplares similares
-
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
por: Nemchenko, Andriy
Publicado: (2012) -
Immunology and Gene Therapy: Shoulder to Shoulder Into the Fray: International Symposium: Critical Frontiers Between Immunity and Gene Therapy
Pamplona, Spain, 27–28 October 2009
por: Smerdou, Cristian, et al.
Publicado: (2010) -
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
por: Morales-Kastresana, Aizea, et al.
Publicado: (2014) -
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2014) -
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
por: Wenthe, Jessica, et al.
Publicado: (2020)